title: Brain PET imaging of phosphodiesterase 10A in progressive supranuclear palsy and Parkinson's disease.
authors.affiliation: Nuclear Medicine and Molecular Imaging, University Hospitals Leuven and KU Leuven, Leuven, Belgium.
authors.forename: Michel
authors.initials: M
authors.lastname: Koole
authors.affiliation: Nuclear Medicine and Molecular Imaging, University Hospitals Leuven and KU Leuven, Leuven, Belgium.
authors.forename: Koen
authors.initials: K
authors.lastname: Van Laere
authors.affiliation: Nuclear Medicine and Molecular Imaging, University Hospitals Leuven and KU Leuven, Leuven, Belgium.
authors.forename: Rawaha
authors.initials: R
authors.lastname: Ahmad
authors.affiliation: Nuclear Medicine and Molecular Imaging, University Hospitals Leuven and KU Leuven, Leuven, Belgium.
authors.forename: Jenny
authors.initials: J
authors.lastname: Ceccarini
authors.affiliation: Laboratory for Radiopharmacy, KU Leuven, Leuven, Belgium.
authors.forename: Guy
authors.initials: G
authors.lastname: Bormans
authors.affiliation: Department of Neurology and Department of Neurosciences, University Hospitals Leuven and KU Leuven, Leuven, Belgium.
authors.forename: Wim
authors.initials: W
authors.lastname: Vandenberghe
mesh_terms: D001921:Brain / Q000000981:diagnostic imaging* / Q000187:drug effects; D005260:Female; D006801:Humans; D008279:Magnetic Resonance Imaging; D008297:Male; D010300:Parkinson Disease / Q000000981:diagnostic imaging*; D010727:Phosphoric Diester Hydrolases / Q000378:metabolism*; D049268:Positron-Emission Tomography; D011720:Pyrazoles / Q000493:pharmacokinetics; D011725:Pyridines / Q000493:pharmacokinetics; D013494:Supranuclear Palsy, Progressive / Q000000981:diagnostic imaging*
chemical_list: C581925:2-((4-(1-(2-fluoroethyl)-4-(4-pyridinyl)-1H-pyrazol-3-yl)phenoxy)methyl)-3,5-dimethylpyridine; D011720:Pyrazoles; D011725:Pyridines; C119843:PDE10A protein, human; D010727:Phosphoric Diester Hydrolases